Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Vatter

Showing results (221-230 of 311) with videos related to

Pageof 32
Sort By:
International Journal of Cancer|April 27, 2026
Prognostic Value of Perioperative Anemia in Neurosurgical-Oncological Treatment of Spinal MetastasesMarija Janjic, Logman Khalafov, Juliane Dittmer, et al.
Neurosurgical Review|January 2, 2023
Unplanned intensive care unit readmission after surgical treatment in patients with newly diagnosed glioblastoma - forfeiture of surgically achieved advantages?Felix Lehmann, Anna-Laura Potthoff, Valeri Borger, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
MR-Imaging and Histopathological Diagnostic Work-Up of Patients with Spontaneous Lobar Intracerebral Hemorrhage: Results of an Institutional Prospective Registry StudyPatrick Schuss, Christian Bode, Valeri Borger, et al.
Neuro-Oncology Advances|June 27, 2025
Second-line temozolomide in first recurrent MGMT-methylated glioblastoma after lomustine/temozolomide: Efficacy and safetyThomas Zeyen, Antonia Treiber, Matthias Schneider, et al.
Frontiers in Oncology|November 15, 2021
Dosimetric Comparison of Upfront Boosting With Stereotactic Radiosurgery Versus Intraoperative Radiotherapy for GlioblastomaGustavo R Sarria, Zuzanna Smalec, Thomas Muedder, et al.
Journal of Neuro-Oncology|October 3, 2023
The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trialJohannes Weller, Thomas Zeyen, Niklas Schäfer, et al.
Cancers|October 14, 2022
Bone Mineral Density as an Individual Prognostic Biomarker in Patients with Surgically-Treated Brain Metastasis from Lung Cancer (NSCLC)Inja Ilic, Anna-Laura Potthoff, Valeri Borger, et al.
Journal of Clinical Medicine|July 2, 2021
Neurosurgical Considerations Regarding Decompressive Craniectomy for Intracerebral Hemorrhage after SARS-CoV-2-Vaccination in Vaccine Induced Thrombotic Thrombocytopenia-VITTFlorian Gessler, Ann Kristin Schmitz, Daniel Dubinski, et al.
Neurosurgical Review|June 29, 2023
Incurring detriments of unplanned readmission to the intensive care unit following surgery for brain metastasisJustus August Schweppe, Anna-Laura Potthoff, Muriel Heimann, et al.
Brain Sciences|June 2, 2021
Predictive Relevance of Baseline Lactate and Glucose Levels in Patients with Spontaneous Deep-Seated Intracerebral HemorrhageFelix Lehmann, Lorena M Schenk, Matthias Schneider, et al.
Pageof 32

Showing results (221-230 of 311) with videos related to

Sort By:
Pageof 32
International Journal of Cancer|April 27, 2026
Prognostic Value of Perioperative Anemia in Neurosurgical-Oncological Treatment of Spinal MetastasesMarija Janjic, Logman Khalafov, Juliane Dittmer, et al.
Neurosurgical Review|January 2, 2023
Unplanned intensive care unit readmission after surgical treatment in patients with newly diagnosed glioblastoma - forfeiture of surgically achieved advantages?Felix Lehmann, Anna-Laura Potthoff, Valeri Borger, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
MR-Imaging and Histopathological Diagnostic Work-Up of Patients with Spontaneous Lobar Intracerebral Hemorrhage: Results of an Institutional Prospective Registry StudyPatrick Schuss, Christian Bode, Valeri Borger, et al.
Neuro-Oncology Advances|June 27, 2025
Second-line temozolomide in first recurrent MGMT-methylated glioblastoma after lomustine/temozolomide: Efficacy and safetyThomas Zeyen, Antonia Treiber, Matthias Schneider, et al.
Frontiers in Oncology|November 15, 2021
Dosimetric Comparison of Upfront Boosting With Stereotactic Radiosurgery Versus Intraoperative Radiotherapy for GlioblastomaGustavo R Sarria, Zuzanna Smalec, Thomas Muedder, et al.
Journal of Neuro-Oncology|October 3, 2023
The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trialJohannes Weller, Thomas Zeyen, Niklas Schäfer, et al.
Cancers|October 14, 2022
Bone Mineral Density as an Individual Prognostic Biomarker in Patients with Surgically-Treated Brain Metastasis from Lung Cancer (NSCLC)Inja Ilic, Anna-Laura Potthoff, Valeri Borger, et al.
Journal of Clinical Medicine|July 2, 2021
Neurosurgical Considerations Regarding Decompressive Craniectomy for Intracerebral Hemorrhage after SARS-CoV-2-Vaccination in Vaccine Induced Thrombotic Thrombocytopenia-VITTFlorian Gessler, Ann Kristin Schmitz, Daniel Dubinski, et al.
Neurosurgical Review|June 29, 2023
Incurring detriments of unplanned readmission to the intensive care unit following surgery for brain metastasisJustus August Schweppe, Anna-Laura Potthoff, Muriel Heimann, et al.
Brain Sciences|June 2, 2021
Predictive Relevance of Baseline Lactate and Glucose Levels in Patients with Spontaneous Deep-Seated Intracerebral HemorrhageFelix Lehmann, Lorena M Schenk, Matthias Schneider, et al.
Pageof 32